BMO Capital analyst John Kim maintained a Hold rating on Easterly Government Properties (DEA – Research Report) on March 27 and set a price target of $24.00. The company’s shares closed last Friday at $19.05, close to its 52-week low of $19.01.
According to TipRanks.com, Kim is a 4-star analyst with an average return of 3.3% and a 53.2% success rate. Kim covers the Financial sector, focusing on stocks such as National Health Investors, Hudson Pacific Properties, and Plymouth Industrial Reit.
The word on The Street in general, suggests a Hold analyst consensus rating for Easterly Government Properties with a $24.00 average price target, which is a 21.8% upside from current levels. In a report issued on March 15, Truist Financial also maintained a Hold rating on the stock with a $24.00 price target.
Easterly Government Properties’ market cap is currently $3.44B and has a P/E ratio of 54.40.
Based on the recent corporate insider activity of 25 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DEA in relation to earlier this year. Most recently, in March 2022, Darrell Crate, the Chairman of DEA sold 175,406 shares for a total of $3,695,896.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Easterly Government Properties, Inc. operates as a real estate investment trust, which engages in the acquisition, development, and management of commercial properties that are leased to U.S. Government agencies. The company was founded on October 10, 2014 and is headquartered in Washington, DC.
Read More on DEA:
- BMO Capital Believes Independence Realty (IRT) Won’t Stop Here
- BMO Capital Sticks to Their Hold Rating for Hudson Pacific Properties (HPP)
- JBG Smith Properties (JBGS) Receives a Buy from BMO Capital
- Kilroy Realty (KRC) Gets a Buy Rating from BMO Capital
- Analysts Offer Insights on Healthcare Companies: and Dyadic International (DYAI)